Penumbra’s stock was up about 14% after the deal was announced Thursday morning.
Source: MarketWatch
Thursday, 15. January 2026
Share:
15. January 2026 14:11
Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments
